Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Payers may balk at Makena pricing, KV says
Fierce Pharma
Wednesday, March 23, 2011 - 11:15am
tags:
Makena, KV Pharmaceutical, drug pricing, premature birth
Omeros' eye surgery drug meets midstage study goals
Yahoo/AP
Wednesday, March 23, 2011 - 11:13am
tags:
Omeros, cataracts
J&J Faces $360M Penalty Over Risperdal Marketing
Pharmalot
Wednesday, March 23, 2011 - 10:34am
tags:
Risperdal, JNJ, Ortho-McNeil-Janssen
Amarin Example Shows Common Sense Is Crucial in Navigating Biotech Sector Volatility
Seeking Alpha
Wednesday, March 23, 2011 - 10:33am
tags:
Amarin, BioDelivery Sciences, Dendreon, Human Genome Sciences, MannKind, Titan, Vanda
What Biotech Wants From Big Pharma Partners: Survey Says!?
InVivo
Wednesday, March 23, 2011 - 10:29am
tags:
Big Pharma, biotech, Roche, Merck, GSK, Novartis, Pfizer, Eli Lilly
Gilead HIV drug meets study goal
Yahoo/AP
Wednesday, March 23, 2011 - 10:28am
tags:
Gilead Sciences, HIV, elvitegravir
Novartis must wait longer for FDA lung drug decision
Reuters
Wednesday, March 23, 2011 - 9:38am
tags:
FDA, COPD, Novartis, QAB149
Good News for ViroPharma Drug
Yahoo/Zacks.com
Wednesday, March 23, 2011 - 9:37am
tags:
ViroPharma, Cinryze, hereditary angiodema
Xoma Says its Diabetes Drug Failed to Lower Blood Sugar
Bloomberg
Wednesday, March 23, 2011 - 9:36am
tags:
diabetes, Xoma, XOMA 052
Pozen inks deal with J&J company for migraine drug
Yahoo/AP
Wednesday, March 23, 2011 - 9:34am
tags:
Pozen, JNJ, migraines, Cilag GmbH, MT-400
InSite cataract drug trial results could target market leader
Bizjournals.com
Tuesday, March 22, 2011 - 10:14pm
tags:
InSite Vision, cataracts, Xibrom, Ista, ISV-303
Failure of Sanofi, Merck Animal-Health Merger May Trigger Deals
Bloomberg
Tuesday, March 22, 2011 - 10:12pm
tags:
animal health, Merck, Sanofi, M&A, Novartis, Bayer
Pharmas in the Doghouse
Motley Fool
Tuesday, March 22, 2011 - 10:06pm
tags:
Merck, Sanofi, Pfizer, Genzyme, Novartis, Eli Lilly, JNJ
Bristol Myers paid new CEO $10.9 million
Yahoo/AP
Tuesday, March 22, 2011 - 10:05pm
tags:
Pharma CEOs, executive pay, Bristol-Myers Squibb, Lamberto Andreotti
Pozen files motion to stop generic Treximet
Bizjournals.com
Tuesday, March 22, 2011 - 11:28am
tags:
generics, Treximet, Pozen
Novartis’s $48,000 Pill Spurs U.S. Price Increases for MS Drugs
Bloomberg
Tuesday, March 22, 2011 - 11:07am
tags:
Novartis, Gilenya, MS, multiple sclerosis, Teva Pharmaceuticals, Biogen Idec, Roche
Amgen in deal with Tesaro
Bizjournals.com
Tuesday, March 22, 2011 - 11:04am
tags:
Amgen, Tesaro, oncology
Sanofi Plans Debt to Fund $20.1 Billion Genzyme Purchase
Bloomberg
Tuesday, March 22, 2011 - 10:08am
tags:
Sanofi, Genzyme, debt
Seattle Genetics Announces Antibody-Drug Conjugate Collaboration with Abbott
Yahoo
Tuesday, March 22, 2011 - 10:05am
tags:
Abbott Laboratories, antibody-drug conjugate, Seattle Genetics
Cancer Drug Stocks to Trade Ahead of ASCO
TheStreet.com
Tuesday, March 22, 2011 - 10:03am
tags:
ASCO, Medivation, Exelixis, Dendreon, Bristol-Myers Squibb, Roche, Curis, Celgene, Sanofi, Ariad Pharmaceuticals, Merck, Incyte, Novartis, YM BioSciences, Pfizer, Aveo Pharmaceutical, ONYX Pharmaceuticals, Amgen, Synta, Vical, Oxigene, Cell Therapeutics, Oncothyreon

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.